BIOMAT Database Logo BIOMAT Database Logo

Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation. 2017

Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.

To explore novel antitumor agents with high efficiency and low toxicity, a series of NO-donating scutellarin derivatives (14-17) were synthesized and the antiproliferative activities against MCF-7, HCT-116, PC-3 and HepG2 cancer cell lines were assessed. Among them, compound 14b was the strongest with IC50 values of 2.96 μM, 7.25 μM, 0.09 μM and 0.50 μM, respectively, and displayed low toxicity against normal human liver L-O2 cells with an IC50 of 47.96 μM, showing good selectivity between normal and malignant liver cells. Moreover, NO releasing ability of the derivatives has been studied. Mechanism studies of the most promising compounds 14b and 15a were carried out. The results indicated that 14b and 15a could induce apoptosis, cell cycle arrest at the S phase and led to mitochondrial dysfunction in the HepG2 and PC-3 cell lines, respectively. Furthermore, Human Apoptosis Protein Array kit assay demonstrated that 14b could induce apoptosis through down-regulating the levels of procaspase-3 and inhibiting the expression of survivin, c-IAP1, HSP27, HSP60, HSP70, HO-1/HMOX1/HSP32 and HO-2/HMOX2 in HepG2 cell line. These results guaranteed compound 14b to be a drug candidate against liver cancer for further investigation.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers.
July 2017, European journal of medicinal chemistry,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, synthesis, and biological evaluation of N-arylpiperazine derivatives as interferon inducers.
December 2020, Bioorganic & medicinal chemistry letters,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Synthesis and biological evaluation of N-phosphoryl dipeptide derivatives as potent apoptosis inducers.
January 2008, Protein and peptide letters,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
March 2005, Bioorganic & medicinal chemistry,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers.
May 2018, Future medicinal chemistry,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluation.
June 2023, Future medicinal chemistry,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers.
April 2019, Bioorganic chemistry,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase-2 inhibitors.
November 2022, Archiv der Pharmazie,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic Mechanism In Vivo.
June 2016, Chemical biology & drug design,
Tong Han, and Jia Li, and Jingjing Xue, and He Li, and Fanxing Xu, and Keguang Cheng, and Dahong Li, and Zhanlin Li, and Ming Gao, and Huiming Hua
Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
November 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!